Moreover, we introduce the first NY-BR-1-specific H2b-restricted CTL epitope and describe the composition of tumor infiltrating immune cell populations with particular focus on NY-BR-1-specific CD4+ T cells and HLA-DR4 positive tumor-associated macrophages. This evidence concerns the gene ANKRD30A and neoplasm.